Novogen forms spinoff, seeks IPO

Novogen (NVGN; ASX:NRT) formed Marshall Edwards Inc., a company that will develop and commercialize phenoxodiol, a synthetic human phenolic hormone inhibitor of various enzymes in Phase I cancer trial...